Logo image of JTAI

JET.AI INC (JTAI) Stock Fundamental Analysis

NASDAQ:JTAI - Nasdaq - US47714H3084 - Common Stock

3.65  +0.05 (+1.39%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to JTAI. JTAI was compared to 23 industry peers in the Passenger Airlines industry. JTAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, JTAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year JTAI has reported negative net income.
JTAI had a negative operating cash flow in the past year.
JTAI Yearly Net Income VS EBIT VS OCF VS FCFJTAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

JTAI's Return On Assets of -335.49% is on the low side compared to the rest of the industry. JTAI is outperformed by 95.65% of its industry peers.
Industry RankSector Rank
ROA -335.49%
ROE N/A
ROIC N/A
ROA(3y)-56.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JTAI Yearly ROA, ROE, ROICJTAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

JTAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JTAI Yearly Profit, Operating, Gross MarginsJTAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

JTAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JTAI has more shares outstanding
The debt/assets ratio for JTAI is higher compared to a year ago.
JTAI Yearly Shares OutstandingJTAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
JTAI Yearly Total Debt VS Total AssetsJTAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

JTAI has an Altman-Z score of -23.62. This is a bad value and indicates that JTAI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of JTAI (-23.62) is worse than 91.30% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.62
ROIC/WACCN/A
WACC8%
JTAI Yearly LT Debt VS Equity VS FCFJTAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.33 indicates that JTAI may have some problems paying its short term obligations.
The Current ratio of JTAI (0.33) is worse than 82.61% of its industry peers.
A Quick Ratio of 0.33 indicates that JTAI may have some problems paying its short term obligations.
With a Quick ratio value of 0.33, JTAI is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
JTAI Yearly Current Assets VS Current LiabilitesJTAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for JTAI have decreased strongly by -6233.48% in the last year.
Looking at the last year, JTAI shows a very strong growth in Revenue. The Revenue has grown by 418.43%.
EPS 1Y (TTM)-6233.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.28%
Revenue 1Y (TTM)418.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.42%

3.2 Future

The Earnings Per Share is expected to grow by 25.40% on average over the next years. This is a very strong growth
JTAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 60.75% yearly.
EPS Next Y40.74%
EPS Next 2Y39.09%
EPS Next 3Y25.4%
EPS Next 5YN/A
Revenue Next Year28.74%
Revenue Next 2Y19.03%
Revenue Next 3Y60.75%
Revenue Next 5YN/A

3.3 Evolution

JTAI Yearly Revenue VS EstimatesJTAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
JTAI Yearly EPS VS EstimatesJTAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JTAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JTAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JTAI Price Earnings VS Forward Price EarningsJTAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JTAI Per share dataJTAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

JTAI's earnings are expected to grow with 25.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.09%
EPS Next 3Y25.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JTAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JET.AI INC

NASDAQ:JTAI (1/22/2025, 11:54:36 AM)

3.65

+0.05 (+1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners0.59%
Inst Owner Change0%
Ins Owners25.14%
Ins Owner Change0%
Market Cap3.07M
Analysts82.86
Price Target20.4 (458.9%)
Short Float %19.55%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.61%
Min EPS beat(2)-11.41%
Max EPS beat(2)-9.8%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.7%
Min Revenue beat(2)-5.78%
Max Revenue beat(2)9.18%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-64.44%
PT rev (3m)1900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22400%
EPS NY rev (1m)0%
EPS NY rev (3m)-9491.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-47.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.51
EYN/A
EPS(NY)-6.16
Fwd EYN/A
FCF(TTM)-7.88
FCFYN/A
OCF(TTM)-7.82
OCFYN/A
SpS17.24
BVpS-4.96
TBVpS-4.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -335.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-56.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover3.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.84%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -23.62
F-Score3
WACC8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6233.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.28%
EPS Next Y40.74%
EPS Next 2Y39.09%
EPS Next 3Y25.4%
EPS Next 5YN/A
Revenue 1Y (TTM)418.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.42%
Revenue Next Year28.74%
Revenue Next 2Y19.03%
Revenue Next 3Y60.75%
Revenue Next 5YN/A
EBIT growth 1Y-332.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.81%
EBIT Next 3Y20.79%
EBIT Next 5YN/A
FCF growth 1Y-46075.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45745.6%
OCF growth 3YN/A
OCF growth 5YN/A